Dr. Robert Snyder Talks About a New Drug to Treat Ezcema
by Riverchase Dermatology
July 16, 2019
share
The new drug, Dupixent, was recently FDA approved to treat people 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.